The Role of Myoferlin in Vesicle Trafficking and the Effects of Its Overexpression in Prostate Cancer
The Tohoku Journal of Experimental Medicine · 2026
DOI: 10.1620/tjem.2025.j161 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2026. Verfasst von Yuki Katsumata und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tohoku University Graduate School of Medicine. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Membrane Proteins, Muscle Proteins, Calcium-Binding Proteins. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Myoferlin (MYOF), a member of the ferlin protein family, is a type II transmembrane protein with a single transmembrane domain at its carboxyl terminus. It plays critical roles in membrane vesicle trafficking, fusion, repair, and endocytosis, and is overexpressed in several cancers, which may contribute to malignant transformation. In this study, we demonstrated that MYOF is overexpressed in human prostate cancer cells, and knockdown of MYOF significantly reduced migration and invasion abilities. We also found that higher levels of MYOF expression were associated with shorter PSA recurrence-free survival times in patients who underwent radical prostatectomy. To our knowledge, this is the first study to demonstrate the clinical significance of MYOF expression in prostate cancer and to identify DNAJC13 as a novel MYOF-interacting protein. These findings suggest that MYOF impacts the malignancy and prognosis of prostate cancer. Additionally, we identified that MYOF interacts with DnaJ heat shock protein family member C13 (DNAJC13), an endosome-associated protein. Immunocytochemistry revealed that MYOF co-localized with DNAJC13 and lysosomes. The newly identified interaction partners of MYOF suggest its involvement in promoting cancer invasion through endosomal and lysosomal pathways. Although functional validation of this interaction remains to be elucidated, our results provide important insights for future mechanistic studies. These findings provide insights into the functional role of MYOF in cancer invasion and metastasis, suggesting that MYOF could be a novel therapeutic target for metastatic prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Tohoku University Graduate School of Medicine.
- Division of Cancer Stem Cells, Miyagi Cancer Center Research Institute.
- Department of Molecular Oncology, Institute of Development, Aging, and Cancer, Tohoku University.
Zitieren
APA
Katsumata, Y., Shimada, S., Katayama, H., Sato, T., Sato, T., Kawasaki, Y., Kawamorita, N., Yamashita, S., Mochizuki, M., Tamai, K., Kanno, S. I., & Ito, A. (2026). The Role of Myoferlin in Vesicle Trafficking and the Effects of Its Overexpression in Prostate Cancer. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.2025.j161
Vancouver
Katsumata Y, Shimada S, Katayama H, Sato T, Sato T, Kawasaki Y, et al. The Role of Myoferlin in Vesicle Trafficking and the Effects of Its Overexpression in Prostate Cancer. The Tohoku Journal of Experimental Medicine. 2026. doi:10.1620/tjem.2025.j161
BibTeX
@article{Katsumata2026,
author = {Katsumata, Yuki and Shimada, Shuichi and Katayama, Hiromichi and Sato, Tomonori and Sato, Takuma and Kawasaki, Yoshihide and Kawamorita, Naoki and Yamashita, Shinichi and Mochizuki, Mai and Tamai, Keiichi and Kanno, Shin-Ichiro and Ito, Akihiro},
title = {The Role of Myoferlin in Vesicle Trafficking and the Effects of Its Overexpression in Prostate Cancer},
journal = {The Tohoku Journal of Experimental Medicine},
year = {2026},
doi = {10.1620/tjem.2025.j161}
}
EUVIMED